Schneider, Peter (2019): There is no such thing as a biosimilar patent cliff?!? - An analysis of price development of biological medicines after patent expiration. 4. Konferenz der Austrian Health Economics Association (ATHEA), 1. März 2019, Wien.
Full text not available from this repository.Item Type: | Conference or Workshop Item (Lecture) |
---|---|
Subjects: | OEBIG > Pharmaoekonomie |
Date Deposited: | 03 Apr 2020 17:01 |
Last Modified: | 03 Apr 2020 18:20 |
URI: | https://jasmin.goeg.at/id/eprint/1314 |